Joseph V. Haas

1.1k total citations
20 papers, 513 citations indexed

About

Joseph V. Haas is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Joseph V. Haas has authored 20 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Surgery. Recurrent topics in Joseph V. Haas's work include Lipoproteins and Cardiovascular Health (3 papers), Genetic Syndromes and Imprinting (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Joseph V. Haas is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Genetic Syndromes and Imprinting (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Joseph V. Haas collaborates with scholars based in United States, Netherlands and Denmark. Joseph V. Haas's co-authors include Kevin L. Duffin, Yoshiya Tanaka, Fabio P. Nunes, Sharon G. Adler, Ravindra L. Mehta, William L. Macias, Frank C. Brosius, Maria Silk, Katherine R. Tuttle and Jiajun Liu and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

In The Last Decade

Joseph V. Haas

20 papers receiving 497 citations

Peers

Countries citing papers authored by Joseph V. Haas

Since Specialization

Citations

This map shows the geographic impact of Joseph V. Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph V. Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph V. Haas more than expected).

Fields of papers citing papers by Joseph V. Haas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph V. Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph V. Haas. The network helps show where Joseph V. Haas may publish in the future.

Co-authorship network of co-authors of Joseph V. Haas

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph V. Haas. A scholar is included among the top collaborators of Joseph V. Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph V. Haas. Joseph V. Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of an NHE3 inhibitor in combination with an NPT2b inhibitor on gastrointestinal phosphate absorption in Rodent models 2024 ·PLoS ONE ·Xiaojun Wang, (unknown), (unknown), Asim Dey, Hong Y. Zhang, (unknown), (unknown), (unknown), (unknown), Charles A. Reidy, Joseph V. Haas, Yanping Xu, Mark C. Kowala, Prabhakar K. Jadhav, John R. Wetterau	1
2	Effects of pharmacological inhibition of the sodium‐dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models 2022 ·Pharmacology Research & Perspectives ·Xiaojun Wang, Yanping Xu, (unknown), Asim Dey, Hong Y. Zhang, (unknown), (unknown), (unknown), William F. Matter, (unknown), Charles A. Reidy, Jeffrey A. Peterson, Brian Mattioni, Joseph V. Haas, Mark C. Kowala, John R. Wetterau	4
3	Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome 2019 ·Physiological Genomics ·Lydia Coulter Kwee, Megan L. Neely, (unknown), Simon G. Gregory, Matthew T. Roe, E. Magnus Ohman, Keith A.A. Fox, Harvey D. White, Paul W. Armstrong, (unknown), Joseph V. Haas, Kevin L. Duffin, Mark Y. Chan, Svati H. Shah	8
4	Use of Plasma Metabolomics and Lipidomics for the Diagnosis of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes 2018 ·Diabetes ·Fernando Bril, Srilaxmi Kalavalapalli, Kevin L. Duffin, Mark L. Hartman, Yu Chen, Qian Yang, Joseph V. Haas, (unknown), Kenneth D. Roth, Kenneth Cusi	1
5	Abstract 17400: Lipoprotein(a) is a Determinant of Residual Cardiovascular Risk in the Setting of Optimal LDL-C in Statin-Treated Patients With Atherosclerotic Cardiovascular Disease 2017 ·Circulation ·Giacomo Ruotolo, Michael Lincoff, Venu Menon, Ellen McErlean, Kathy Wolski, Joseph V. Haas, Govinda J. Weerakkody, Jeffrey Riesmeyer, Steven E. Nissen, Stephen J. Nicholls	2
6	JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial 2017 ·Nephrology Dialysis Transplantation ·Katherine R. Tuttle, Frank C. Brosius, Sharon G. Adler, Matthias Kretzler, Ravindra L. Mehta, James A. Tumlin, Yoshiya Tanaka, Masakazu Haneda, Jiajun Liu, Maria Silk, Tracy Cardillo, Kevin L. Duffin, Joseph V. Haas, William L. Macias, Fabio P. Nunes, Jonathan Janes	210
7	SO014A NOVEL URINARY BIOMARKER OF TYPE VI COLLAGEN FORMATION AND ENDOTROPHIN IS ASSOCIATED WITH LOSS OF KIDNEY FUNCTION IN PATIENTS WITH DIABETIC NEPHROPATHY 2017 ·Nephrology Dialysis Transplantation ·Federica Genovese, Daniel Bech Rasmussen, (unknown), Joseph V. Haas, James R. Voelker, M.A. Karsdal, Kevin L. Duffin	2
8	Concordant Changes of Plasma and Kidney MicroRNA in the Early Stages of Acute Kidney Injury: Time Course in a Mouse Model of Bilateral Renal Ischemia-Reperfusion 2014 ·PLoS ONE ·(unknown), James S. Bean, (unknown), Kathleen M. Heinz-Taheny, (unknown), Joseph V. Haas, Laura F. Michael, Mark D. Rekhter	40
9	Genome-wide Screen for Modulation of Hepatic Apolipoprotein A-I (ApoA-I) Secretion 2013 ·Journal of Biological Chemistry ·Rebecca R. Miles, William L. Perry, Joseph V. Haas, Marian Mosior, (unknown), (unknown), Peng Yu, John Calley, Yong Yue, (unknown), Bomie Han, Patricia Foxworthy, Mark C. Kowala, Timothy P. Ryan, Patricia J. Solenberg, Laura F. Michael	9
10	Minimum Significant Ratio – A Statistic to Assess Assay Variability 2013 ·Europe PMC (PubMed Central) ·Joseph V. Haas, Brian J. Eastwood, Philip W. Iversen, Viswanath Devanarayan, Jeffrey R. Weidner	9
11	In Vivo Assay Guidelines 2012 ·Europe PMC (PubMed Central) ·Joseph V. Haas, Jason R. Manro, Harlan E. Shannon, (unknown), (unknown), Arunava Chakravartty, M.G. Chambers, Jianbin Du, Brian J. Eastwood, (unknown), Stephen J. Iturria, Philip W. Iversen, D. Brooke Johnson, Kirk W. Johnson, Michael F. O‘Neill, Hui-Rong Qian, Dana K. Sindelar, Kjell Svensson	1
12	Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population 2010 ·Atherosclerosis ·Qin Cui, (unknown), Tao Yang, Mei Zhang, Wei Tang, Qi Chen, Yong Hu, Joseph V. Haas, Jason S. Troutt, Richard T. Pickard, Ryan J. Darling, Robert J. Konrad, Hongwen Zhou, Guoqing Cao	109
13	An Animal Model of Emotional Blunting in Schizophrenia 2007 ·PLoS ONE ·Charmaine Y. Pietersen, Fokko J. Bosker, Janine Doorduin, Minke E. Jongsma, Folkert Postema, Joseph V. Haas, Michael P. Johnson, Tineke Koch, Tony Vladusich, Johan A. den Boer	24
14	Effects of linezolid on staphylococcal adherence versus time of treatment 2004 ·International Journal of Antimicrobial Agents ·(unknown), Lewis V. Buchanan, (unknown), Joseph V. Haas, (unknown), John K. Gibson	17
15	Basic Guidelines for Reporting Non-Clinical Data 2004 ·Jayme L. Dahlin, G. Sitta Sittampalam, Nathan P. Coussens, Viswanath Devanarayan, Jeffrey R. Weidner, Philip W. Iversen, Joseph V. Haas, D Bronson, O. Joseph Trask, (unknown), Steven D. Kahl	3
16	Dopamine receptor agonists differ in their actions on cardiac ion channels 2003 ·European Journal of Pharmacology ·Raymond S Hurst, Nicole R. Higdon, Judy A. Lawson, M. A. Clark, (unknown), William Graham McDonald, Joseph V. Haas, (unknown), Martin D. Meglasson	21
17	Efficacy of Linezolid plus Rifampin in an Experimental Model of Methicillin-Susceptible Staphylococcus aureus Endocarditis 2003 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), Lewis V. Buchanan, (unknown), Joseph V. Haas, John K. Gibson	32
18	PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson’s Disease 2002 ·Neuropharmacology ·(unknown), Maria Cimini, Joseph V. Haas, Brian A. Staton, Joakim Tedroff, Kjell Svensson	12
19	Rank-Based Procedures for Linear Models: Applications to Pharmaceutical Science Data 2001 ·Drug Information Journal ·Asheber Abebe, Kimberly Crimin, Joseph W. McKean, Joseph V. Haas, Thomas J. Vidmar	7
20	Attenuation of Oxidant-Induced Lung Injury by 21-Aminosteroids (Lazaroids): Correlation with the mRNA Expression for E-Selectin, P-Selectin, ICAM-1, and VCAM-1 1994 ·Environmental Health Perspectives ·Robert L. Griffin, R F Krzesicki, S F Fidler, (unknown), John A. Auchampach, Anthony M. Manning, Joseph V. Haas, Sue Cammarata, Jia En Chin, I M Richards	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact